WARNINGS
Transient episodes of dizziness, weakness, or syncope or other signs of cerebral ischemia due to postural hypotension may develop following inhalation of amyl
nitrite, particularly if the patient is standing immobile. To hasten recovery,
measures which facilitate venous return such as head-low posture, deep breathing
and movement of extremities may be used.
CAUTION: Amyl Nitrite (amyl nitrite inhalant) is very flammable. Do not use where it might become
ignited.
PRECAUTIONS
General
Tolerance to amyl nitrite (amyl nitrite inhalant) may develop with repeated use of the drug for prolonged
periods of time. Tolerance may be minimized by beginning with the smallest effective
dose and alternating the drug with another coronary vasodilator.
High doses of nitrites may produce methemoglobinemia, especially in individuals
with methemoglobin reductase deficiency or other metabolic abnormality that
interferes with the normal conversion of methemoglobin back to hemoglobin.
Carcinogenesis, Mutagenesis, Fertility Impairment
Adequate long term studies to establish adverse carcinogenic potential of
this drug have not been reported.
Pregnancy
Teratogenic effects:
Category C. Animal studies have not been conducted with amyl nitrite (amyl nitrite inhalant) ,
It is also not known whether amyl nitrite (amyl nitrite inhalant) can cause fetal harm when administered
to a pregnant woman or can affect reproduction capacity. Amyl nitrite (amyl nitrite inhalant) should
be given to a pregnant woman only if clearly needed.
Nursing Mothers
It is not known whether this drug is excreted in human milk. Because many
drugs are excreted in human milk, caution should be exercised when amyl nitrite (amyl nitrite inhalant)
is administered to a nursing woman.
Pediatric Use
Safety and effectiveness in children have not been established.